JRSIS Health Care Corporation (JRSS)
OTCMKTS
· Delayed Price · Currency is USD
0.0225
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
JRSIS Health Care Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Revenue | 3.47 | 3.46 | 1.72 | - | 35.71 | 31.46 | Upgrade
|
| Revenue Growth (YoY) | 14.52% | 101.38% | - | - | 13.48% | 10.78% | Upgrade
|
| Cost of Revenue | 3.03 | 2.98 | 1.69 | - | 24.13 | 20.59 | Upgrade
|
| Gross Profit | 0.44 | 0.48 | 0.03 | - | 11.57 | 10.88 | Upgrade
|
| Selling, General & Admin | 0.98 | 0.48 | 0.43 | 0.1 | 2.33 | 2.44 | Upgrade
|
| Research & Development | 0.13 | 0.19 | 0.28 | - | - | - | Upgrade
|
| Operating Expenses | 1.12 | 0.67 | 0.71 | 0.1 | 5.02 | 4.65 | Upgrade
|
| Operating Income | -0.68 | -0.19 | -0.68 | -0.1 | 6.55 | 6.22 | Upgrade
|
| Interest Expense | -0.05 | -0.06 | -0.06 | - | -1.14 | -1.11 | Upgrade
|
| Interest & Investment Income | 0 | 0 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.16 | 0.16 | 0.08 | 0 | -0.54 | -2.85 | Upgrade
|
| EBT Excluding Unusual Items | -0.57 | -0.09 | -0.67 | -0.1 | 4.87 | 2.26 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.32 | -0.33 | Upgrade
|
| Pretax Income | -0.57 | -0.09 | -0.67 | -0.1 | 5.2 | 1.93 | Upgrade
|
| Income Tax Expense | 0 | 0.01 | - | - | 1.37 | 0.66 | Upgrade
|
| Earnings From Continuing Operations | -0.57 | -0.09 | -0.67 | -0.1 | 3.83 | 1.27 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 3.29 | - | - | Upgrade
|
| Net Income to Company | -0.57 | -0.09 | -0.67 | 3.19 | 3.83 | 1.27 | Upgrade
|
| Minority Interest in Earnings | 0.08 | 0.01 | 0.1 | - | -1.15 | -0.38 | Upgrade
|
| Net Income | -0.49 | -0.08 | -0.58 | 3.19 | 2.68 | 0.89 | Upgrade
|
| Net Income to Common | -0.49 | -0.08 | -0.58 | 3.19 | 2.68 | 0.89 | Upgrade
|
| Net Income Growth | - | - | - | 19.03% | 201.68% | -55.44% | Upgrade
|
| Shares Outstanding (Basic) | 83 | 77 | 61 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 77 | 61 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | -28.30% | 25.95% | 3186.66% | 2.14% | 8.86% | -6.44% | Upgrade
|
| EPS (Basic) | -0.01 | -0.00 | -0.01 | 1.73 | 1.48 | 0.53 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.00 | -0.01 | 1.73 | 1.47 | 0.53 | Upgrade
|
| EPS Growth | - | - | - | 17.89% | 177.13% | -52.38% | Upgrade
|
| Free Cash Flow | -0.73 | 0.52 | -1.76 | 8.23 | 2.37 | 7.13 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.01 | -0.03 | 4.41 | 1.30 | 4.25 | Upgrade
|
| Gross Margin | 12.74% | 13.95% | 1.52% | - | 32.41% | 34.57% | Upgrade
|
| Operating Margin | -19.47% | -5.45% | -39.83% | - | 18.34% | 19.78% | Upgrade
|
| Profit Margin | -14.12% | -2.34% | -33.50% | - | 7.50% | 2.82% | Upgrade
|
| Free Cash Flow Margin | -21.08% | 14.88% | -102.65% | - | 6.64% | 22.67% | Upgrade
|
| EBITDA | -0.63 | -0.13 | -0.65 | 3.21 | 9.24 | 8.43 | Upgrade
|
| EBITDA Margin | -18.06% | -3.89% | -37.80% | - | 25.89% | 26.81% | Upgrade
|
| D&A For EBITDA | 0.05 | 0.05 | 0.03 | 3.31 | 2.7 | 2.21 | Upgrade
|
| EBIT | -0.68 | -0.19 | -0.68 | -0.1 | 6.55 | 6.22 | Upgrade
|
| EBIT Margin | -19.47% | -5.45% | -39.83% | - | 18.34% | 19.78% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 26.35% | 34.14% | Upgrade
|
| Revenue as Reported | - | - | - | - | 35.71 | 31.46 | Upgrade
|
| Advertising Expenses | - | 0.08 | 0 | - | 0.13 | 0.05 | Upgrade
|
Updated Dec 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.